Viewing Study NCT03720561


Ignite Creation Date: 2025-12-24 @ 1:02 PM
Ignite Modification Date: 2025-12-29 @ 9:21 PM
Study NCT ID: NCT03720561
Status: COMPLETED
Last Update Posted: 2022-01-03
First Post: 2018-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting
Sponsor: Janssen-Cilag S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module